Skip to main content
Autobound logo
Edwards Lifesciences10-K: Product launch

R&D spending increased to 18% of sales in 2025, focused on new transcatheter therapies

Read at SEC EDGAR

What happened

Edwards increased R&D spending by 2% year-over-year, representing a significant budget of approximately 18% of 2025 sales. This investment is specifically targeted at advancing transcatheter structural heart programs (mitral, aortic, tricuspid), signaling major spending on clinical trials, product development, and regulatory submissions.

Source

SEC EDGARFeb 25, 2026

Annual report (Form 10-K)

Edwards Lifesciences 10-K for FY2025

Filing excerpt

Research and development spending increased approximately 2% year over year, representing approximately 18% of 2025 sales.

sec.gov/Archives/edgar/data/1099800/000109980026000009/ew-20251231.htmRead the full source

Other signals in this filing (10)

Extracted by Autobound

From the Signal API record
Signal
10-K: Product launch

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 25, 2026

More from Edwards Lifesciences

Company page →

More 10-K signals at other companies

The full record

From the Signal API record

Numbers

Percent
18% (of 2025 sales allocated to Research and Development)

Details

CIK
1099800
Accession number
0001099800-26-000009
Timeframe
Current year
Filing year
2026
Why it matters
Go-to-market support
Signal category
Strategic

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Mar 3, 2026
signal_type
sec-10k
signal_subtype
productLaunch

Use this data

Get every 10-K signal for Edwards Lifesciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Edwards Lifesciences this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/671b2585-b796-46fd-a7a0-5d7c4d144d99 returns this record as JSON. POST /v1/companies/enrich returns every signal for edwards.com.

{
  "signal_id": "671b2585-b796-46fd-a7a0-5d7c4d144d99",
  "signal_type": "sec-10k",
  "signal_subtype": "productLaunch",
  "detected_at": "2026-03-03T05:54:08.55+00:00",
  "company": {
    "name": "Edwards Lifesciences",
    "domain": "edwards.com"
  },
  "data": {
    "detail": "Edwards increased R&D spending by 2% year-over-year, representing a significant budget of approximately 18% of 2025 sales. This investment is specifically targeted at advancing transcatheter structural heart programs (mitral, aortic, tricuspid), signaling major spending on clinical trials, product development, and regulatory submissions.",
    "metrics": {
      "pct": 0.18,
      "timeframe": "current_year",
      "pct_context": "of 2025 sales allocated to Research and Development"
    },
    "summary": "R&D spending increased to 18% of sales in 2025, focused on new transcatheter therapies",
    "excerpts": "Research and development spending increased approximately 2% year over year, representing approximately 18% of 2025 sales.",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1099800/000109980026000009/ew-20251231.htm",
    "filing_date": "2026-02-25",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Go-to-market support",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.